Tumor suppressor functions of ARLTS1 in lung cancers

Cancer Research

Volumn 67, Issue 16, 2007, Pages 7738-7745

  Yendamuri, Sai ^a   Trapasso, Francesco ^a,c,e   Ferracin, Manuela ^d   Cesari, Rossano ^a   Sevignani, Cinzia ^a   Shimizu, Masayoshi ^a,f   Rattan, Shashi ^a   Kuroki, Tamotsu ^a   Dumon, Kristoffel R ^b   Bullrich, Florencia ^a   Liu, Chang Gong ^a,e   Negrini, Massimo ^d   Williams, Noel N ^b   Kaiser, Larry R ^b   Croce, Carlo M ^a,e   Calin, George A ^a,f  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; LUNG CANCER; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADENOVIRIDAE; ADP-RIBOSYLATION FACTORS; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CONSERVED SEQUENCE; DNA METHYLATION; DOWN-REGULATION; GENE THERAPY; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SEQUENCE ALIGNMENT;

EID: 34548049246     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1481     Document Type: Article

References (23)

1. Calin GA, Trapasso F, Masayoshi S, et al. Familial cancer associatedwith a polymorphism in ARLTS1. N Engl J Med 2005;352:1667-76.
2. Kahn RA, Der CJ, Bokoch GM. The ras superfamily of GTP-binding proteins: guidelines on nomenclature. FASEB J 1992;6:2512-13.
3. Kahn RA, Volpicelli-Daley L, Bowzard B, et al. Arf family GTPases: roles in membrane traffic and microtubule dynamics. Biochem Soc Trans 2005;33:1269-72.
4. Frank B, Hemminki K, Brenner H, Hoffmeister M, Chang-Claude J, Burwinkel B. ARLTS1 variants and risk of colorectal cancer. Cancer Lett 2006;244:172-5.
5. Frank B, Hemminki K, Meindl A, et al. Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk. Int J Cancer 2005;118:2505-8.
6. Petrocca F, Iliopoulos D, Qin HR, et al. Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer. Cancer Res 2006;66:10287-91.
7. Moss J, Vaughan M. Molecules in the ARF orbit. J Biol Chem 1998;273:21431-4.
8. Omeis IA, Hsu YC, Perin MS. Mouse and human neuronal pentraxin 1 (NPTX1): conservation, genomic structure, and chromosomal localization. Genomics 1996;36:543-5.
9. Chao CH, Chen CM, Cheng PL, Shih JW, Tsou AP, Lee YH. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor. Cancer Res 2006;66:6579-88.
10. Chang PC, Chi CW, Chau GY, et al. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control. Oncogene 2006;25:1991-2003.
11. Barradas M, Gonos ES, Zebedee Z, et al. Identification of a candidate tumor-suppressor gene specifically activated during Ras-induced senescence. Exp Cell Res 2002;273:127-37.
12. Campbell S, Michaelson J, Burkly L, Putterman C. The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity. Front Biosci 2004;9:2273-84.
13. Zhao Z, Ho L, Suh J, et al. A role of P301L tau mutant in anti-apoptotic gene expression, cell cycle and apoptosis. Mol Cell Neurosci 2003;24:367-79.
14. Stehlik C, Hayashi H, Pio F, Godzik A, Reed JC. CARD6 is a modulator of NF-κB activation by Nod1- and Cardiak-mediated pathways. J Biol Chem 2003;278:31941-9.
15. Faucheu C, Diu A, Chan AWE, et al. A novel human protease similar to the interleukin-1β converting enzyme induces apoptosis in transfected cells. EMBO J 1995;14:1914-22.
16. Frank B, Klaes R, Burwinkel B. Familial cancer and ARLTS1. N Engl J Med 2005;353:313-4.
17. Frank B, Meyer P, Boettger MB, et al. ARLTS1 variants and melanoma risk. Int J Cancer 2006;119:1736-7.
18. Masojc B, Mierzejewski M, Cybulski C, et al. Cancer familial aggregation (CFA) and G446A polymorphism in ARLTS1 gene. Breast Cancer Res Treat 2006;99:59-62.
19. Sellick GS, Catovsky D, Houlston RS. Relationship between ARLTS1 polymorphisms and risk of chronic lymphocytic leukemia. Leuk Res 2006;30:1573-6.
20. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002;99:15524-9.
21. Yin Z, Spitz MR, Babaian RJ, Strom SS, Troncoso P, Kagan J. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. Oncogene 1999;18:7576-83.
22. La Starza R, Wlodarska I, Aventin A, et al. Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies. Blood 1998;91:231-7.
23. Carrasco DR, Tonon G, Huang Y, et al. High-resolution genomic profiles define distinct clinicopathogenetic subgroups of multiple myeloma patients. Cancer Cell 2006;9:313-25.